zoster-related pain
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. The subjects volunteered and signed the informed consent form for the trial. 2. The age is under 18 years old, female patients during pregnancy or lactation. 3. Patients with acute herpetic neuralgia, subacute herpetic neuralgia , post-herpetic neuralgia. 4. Patients with VAS >= 4 before treatment or severe adverse reactions (dizziness, drowsiness, etc.) after drug treatment. 5. Planning to receiving pulsed radiofrequency PRF therapy. 6. The cognitive function is normal, can describe the symptoms objectively and cooperate activel
Exclusion criteria
Exclusion criteria: 1. Those who do not meet the inclusion criteria, or who are determined by the doctor to be unsuitable to participate in this trial. 2. Serious cardiopulmonary diseases. 3. Patients with severe hepatic and renal insufficiency. 4. Complicated with coagulation system disease or local infection. 5. VR devices can not be used. 6. Severe cardiac, hepatic and renal insufficiency. 7. Cognitive impairment, unable to communicate and unable to cooperate with the respondents. 8. The researchers believe that there are any reasons why they can not be selected.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| pain relief rate after three months; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain relief rate at discharge;Pain relief rate after discharge 1 month;pain catastrophizing score;Morphine Milligram Equivalents;Type of medication;Pittsburgh Sleep Quality Index;Hospital Anxiety and Depression Scale;Satisfaction score;incidence of adverse reactions; | — |
Countries
China
Contacts
West China Hospital,Sichuan University